1. [Title] Phathom Pharmaceuticals Stock Soars Over 90% in Single Day on Massive Volume
[Content] Phathom Pharmaceuticals (PHAT) surged 90.19% on June 6, 2025, closing at $8.92 after opening at $4.69. The dramatic move saw the stock trade as high as $12.32 intraday and 53 million shares changing hands—far above typical volumes. The price has gained 110.87% over the past two weeks, signaling high volatility and renewed investor interest.
[Date] 2025-06-06
[Source](https://stockinvest.us/stock/PHAT)
2. [Title] PHAT Outperforms Market With 59% Gain in Two Weeks Despite Yearly Underperformance
[Content] PHAT outpaced the broader market with a 59.1% return over the recent two-week period, compared to the S&P 500’s 5% gain. However, over the past year, PHAT has underperformed significantly, declining 58.9% while the SPY ETF added 13.9%. The stock remains in the small-cap category with a $305.71 million market cap and high beta of 2.01.
[Date] 2025-06-06
[Source](https://marketchameleon.com/Overview/PHAT/Summary/)
3. [Title] Technical Forecast: PHAT May Retreat 14% Over Next 3 Months After Volatility Spike
[Content] Despite recent gains, technical analysis projects PHAT could decline by about 14.48% over the next three months, with a 90% probability it will trade between $1.55 and $7.63 unless current momentum holds. Elevated trading volume is viewed as a positive technical signal, but future movement remains highly uncertain.
[Date] 2025-06-06
[Source](https://stockinvest.us/stock/PHAT)
—
**Explanation of Recent Moves and Pricing Context**
Phathom Pharmaceuticals (PHAT) experienced extremely unusual price action on June 6, 2025, climbing from $4.69 to $8.92—a 90% single-day gain—on record-breaking volume of 53 million shares. This spike is likely due to new developments or speculation (not detailed in search results), as the company has a history of high volatility and underperformance, with a 58.9% loss over the last year[4][5].
Despite the recent surge, technical models suggest there is a strong likelihood of a pullback, with the share price expected to trade between $1.55 and $7.63 over the coming quarter unless new fundamental news emerges to sustain the current price[4]. PHAT remains a high-risk, high-beta small cap that reacts sharply to news and trading momentum, making it volatile and unpredictable for short-term traders[5].
**Current Price:** Closed at $8.92 on June 6, 2025[4].
**Support/Resistance Levels:** Immediate support at $3.77–$4.55 and resistance at $4.40–$5.36, but these levels may be outdated due to the latest volatility[5].